tiprankstipranks
Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
PremiumThe FlyAvadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
2M ago
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
PremiumThe Fly
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
2M ago
Avadel Pharmaceuticals ‘pleased’ with ruling in patent litigation with Jazz Pharmaceuticals
PremiumThe Fly
Avadel Pharmaceuticals ‘pleased’ with ruling in patent litigation with Jazz Pharmaceuticals
2M ago
Jazz Pharmaceuticals price target lowered to $173 from $184 at BofA
PremiumThe FlyJazz Pharmaceuticals price target lowered to $173 from $184 at BofA
2M ago
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
PremiumPress Releases
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
2M ago
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
PremiumPress Releases
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
2M ago
Jazz Pharmaceuticals Welcomes New CFO with Strong Financial Expertise
PremiumCompany AnnouncementsJazz Pharmaceuticals Welcomes New CFO with Strong Financial Expertise
2M ago
Jazz Pharmaceuticals appoints Philip Johnson as CFO
PremiumThe Fly
Jazz Pharmaceuticals appoints Philip Johnson as CFO
2M ago
Jazz to acquire KRAS inhibitor program from Redx Pharma for $10M upfront
PremiumThe Fly
Jazz to acquire KRAS inhibitor program from Redx Pharma for $10M upfront
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100